Item Type | Name |
Academic Article
|
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
|
Academic Article
|
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
|
Academic Article
|
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.
|
Concept
|
Adenocarcinoma
|
Concept
|
Adenocarcinoma, Clear Cell
|
Concept
|
Adenocarcinoma, Mucinous
|
Concept
|
Adenocarcinoma, Papillary
|
Academic Article
|
Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer.
|
Academic Article
|
Molecular changes in the bronchial epithelium of patients with small cell lung cancer.
|
Academic Article
|
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.
|
Academic Article
|
Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
|
Academic Article
|
Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.
|
Academic Article
|
Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.
|
Academic Article
|
Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
|
Academic Article
|
Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
|
Academic Article
|
Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.
|
Academic Article
|
Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line.
|
Academic Article
|
HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men.
|
Academic Article
|
HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma.
|
Academic Article
|
The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
|
Academic Article
|
Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.
|
Academic Article
|
Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
|
Academic Article
|
Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.
|
Academic Article
|
Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
|
Academic Article
|
Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.
|
Academic Article
|
Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
|
Academic Article
|
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
|
Academic Article
|
Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.
|
Academic Article
|
Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.
|
Academic Article
|
Pancreatic intraepithelial neoplasia.
|
Academic Article
|
Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract.
|
Academic Article
|
Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma.
|
Academic Article
|
Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags.
|
Academic Article
|
Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy.
|
Academic Article
|
CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.
|
Academic Article
|
A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment.
|
Academic Article
|
Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.
|
Academic Article
|
Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays.
|
Academic Article
|
The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway.
|
Academic Article
|
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
|
Academic Article
|
Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.
|
Academic Article
|
In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.
|
Academic Article
|
Cystic precursors to invasive pancreatic cancer.
|
Academic Article
|
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
|
Academic Article
|
Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.
|
Academic Article
|
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.
|
Academic Article
|
Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.
|
Academic Article
|
miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.
|
Academic Article
|
The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.
|
Academic Article
|
A broad survey of cathepsin K immunoreactivity in human neoplasms.
|
Academic Article
|
Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.
|
Academic Article
|
Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma.
|
Academic Article
|
Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases.
|
Academic Article
|
Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.
|
Academic Article
|
Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging.
|
Academic Article
|
Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms.
|
Academic Article
|
Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer.
|
Academic Article
|
Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression.
|
Academic Article
|
Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.
|
Academic Article
|
Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms.
|
Academic Article
|
Genome-wide aberrations in pancreatic adenocarcinoma.
|
Academic Article
|
Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.
|
Academic Article
|
MKK4 status predicts survival after resection of gastric adenocarcinoma.
|
Academic Article
|
Current topics on precursors to pancreatic cancer.
|
Academic Article
|
Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.
|
Academic Article
|
Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts.
|
Academic Article
|
Expression of Yes-associated protein in common solid tumors.
|
Academic Article
|
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia.
|
Academic Article
|
Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma.
|
Academic Article
|
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.
|
Academic Article
|
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas.
|
Academic Article
|
Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.
|
Academic Article
|
MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.
|
Academic Article
|
Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
|
Academic Article
|
Gene expression profiling identifies markers of ampullary adenocarcinoma.
|
Academic Article
|
Precursors to invasive pancreatic cancer.
|
Academic Article
|
Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
|
Academic Article
|
Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
|
Academic Article
|
Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer.
|
Academic Article
|
Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma.
|
Academic Article
|
Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
|
Academic Article
|
GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.
|
Academic Article
|
Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases.
|
Academic Article
|
CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.
|
Academic Article
|
Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution.
|
Academic Article
|
Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon.
|
Academic Article
|
Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.
|
Academic Article
|
Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
|
Academic Article
|
Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia.
|
Academic Article
|
Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.
|
Academic Article
|
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
|
Academic Article
|
Human correlates of provocative questions in pancreatic pathology.
|
Academic Article
|
APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
|
Academic Article
|
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
|
Academic Article
|
Molecular characteristics of pancreatic ductal adenocarcinoma.
|
Academic Article
|
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.
|
Academic Article
|
Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.
|
Academic Article
|
Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma.
|
Academic Article
|
Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism.
|
Academic Article
|
Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.
|
Academic Article
|
Whole genomes redefine the mutational landscape of pancreatic cancer.
|
Academic Article
|
Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
|
Academic Article
|
Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Subtyping Pancreatic Cancer.
|
Academic Article
|
In?Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.
|
Academic Article
|
Genetics and biology of pancreatic ductal adenocarcinoma
|
Academic Article
|
P53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells
|
Academic Article
|
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma
|
Academic Article
|
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma
|
Academic Article
|
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival
|
Academic Article
|
Targeting chemokine pathways in esophageal adenocarcinoma.
|
Academic Article
|
Genetics and biology of pancreatic ductal adenocarcinoma.
|
Academic Article
|
Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.
|
Academic Article
|
Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant?
|
Academic Article
|
Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.
|
Academic Article
|
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
|
Academic Article
|
Quantitative imaging to evaluate malignant potential of IPMNs.
|
Academic Article
|
Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.
|
Academic Article
|
Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival.
|
Academic Article
|
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.
|
Academic Article
|
Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma.
|
Academic Article
|
Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.
|
Academic Article
|
Pancreatic Cancer Genomics 2.0: Profiling Metastases.
|
Academic Article
|
Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy.
|
Academic Article
|
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
|
Academic Article
|
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy.
|
Academic Article
|
The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.
|
Academic Article
|
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
|
Academic Article
|
Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.
|
Academic Article
|
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer.
|
Academic Article
|
First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
|
Academic Article
|
Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2a in Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity.
|
Academic Article
|
Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.
|
Academic Article
|
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
|
Academic Article
|
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
|
Academic Article
|
Hear Pancreatic Cancer Stem Cells ROR.
|
Concept
|
Adenocarcinoma in Situ
|
Academic Article
|
Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.
|
Academic Article
|
Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update.
|
Academic Article
|
Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.
|
Academic Article
|
YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma.
|
Academic Article
|
Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
|
Academic Article
|
Recent insights into the biology of pancreatic cancer.
|
Academic Article
|
Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.
|
Academic Article
|
Plasma-Derived Extracellular Vesicles Convey Protein Signatures that Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas.
|
Academic Article
|
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.
|
Academic Article
|
Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples.
|
Academic Article
|
Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study.
|
Academic Article
|
Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.
|
Academic Article
|
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival.
|
Academic Article
|
PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
|
Academic Article
|
GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first.
|
Academic Article
|
Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.
|
Academic Article
|
CES2 sustains HNF4a expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop.
|
Academic Article
|
Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
|
Academic Article
|
Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.
|
Academic Article
|
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience.
|
Academic Article
|
Implementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Translational advances in pancreatic ductal adenocarcinoma therapy.
|
Academic Article
|
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes.
|
Academic Article
|
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception.
|
Academic Article
|
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.
|
Academic Article
|
A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma.
|
Academic Article
|
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma.
|
Academic Article
|
The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.
|
Academic Article
|
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy.
|
Academic Article
|
Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.
|
Academic Article
|
Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy.
|
Academic Article
|
Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.
|
Academic Article
|
Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes.
|
Academic Article
|
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
|
Academic Article
|
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.
|